數碼科技(300079.SZ):博彙科技IPO定價28.77元/股 將於6月12日正式登陸科創板
格隆匯6月2日丨數碼科技(300079.SZ)公佈,近日,公司從參股公司博彙科技處獲悉,博彙科技首次公開發行的A股股票將於2020年6月12日在上交所科創板上市。
根據博彙科技《首次公開發行股票科創板上市公告書》,博彙科技股票在上交所科創板上市,證券簡稱“博彙科技”,證券代碼“688004”,發行價28.77元/股,發行數量1420萬股,此次發行後博彙科技總股本為5680萬股(每股面值1.00元)。
此次發行前公司持有博彙科技638萬股股份,佔博彙科技總股本的14.98%;此次發行後公司持有博彙科技638萬股股份,佔博彙科技總股本的11.23%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.